(Q50040740)

English

Therapeutic efficacy of oral immunization with attenuated Salmonella typhimurium expressing Helicobacter pylori CagA, VacA and UreB fusion proteins in mice model.

scientific article published on 13 July 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 February 2018

http://europepmc.org/abstract/MED/21745524

Therapeutic efficacy of oral immunization with attenuated Salmonella typhimurium expressing Helicobacter pylori CagA, VacA and UreB fusion proteins in mice model. (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 February 2018

http://europepmc.org/abstract/MED/21745524

0 references

Helicobacter pylori

1 reference

based on heuristic

inferred from title

Salmonella Typhimurium

1 reference

based on heuristic

inferred from title

author name string

Kai-Yun Liu

1

1 reference

Europe PubMed Central

PubMed publication ID

23 February 2018

http://europepmc.org/abstract/MED/21745524

Yun Shi

2

1 reference

Europe PubMed Central

PubMed publication ID

23 February 2018

http://europepmc.org/abstract/MED/21745524

Ping Luo

3

1 reference

Europe PubMed Central

PubMed publication ID

23 February 2018

http://europepmc.org/abstract/MED/21745524

Shu Yu

4

1 reference

Europe PubMed Central

PubMed publication ID

23 February 2018

http://europepmc.org/abstract/MED/21745524

Li Chen

5

1 reference

Europe PubMed Central

PubMed publication ID

23 February 2018

http://europepmc.org/abstract/MED/21745524

Zhuo Zhao

6

1 reference

Europe PubMed Central

PubMed publication ID

23 February 2018

http://europepmc.org/abstract/MED/21745524

Xu-Hu Mao

7

1 reference

Europe PubMed Central

PubMed publication ID

23 February 2018

http://europepmc.org/abstract/MED/21745524

Gang Guo

8

1 reference

Europe PubMed Central

PubMed publication ID

23 February 2018

http://europepmc.org/abstract/MED/21745524

Chao Wu

9

1 reference

Europe PubMed Central

PubMed publication ID

23 February 2018

http://europepmc.org/abstract/MED/21745524

Quan-Ming Zou

10

1 reference

Europe PubMed Central

PubMed publication ID

23 February 2018

http://europepmc.org/abstract/MED/21745524

language of work or name

0 references

publication date

13 July 2011

1 reference

Europe PubMed Central

PubMed publication ID

23 February 2018

http://europepmc.org/abstract/MED/21745524

1 reference

Europe PubMed Central

PubMed publication ID

23 February 2018

http://europepmc.org/abstract/MED/21745524

29

1 reference

Europe PubMed Central

PubMed publication ID

23 February 2018

http://europepmc.org/abstract/MED/21745524

38

1 reference

Europe PubMed Central

PubMed publication ID

23 February 2018

http://europepmc.org/abstract/MED/21745524

6679-6685

1 reference

Europe PubMed Central

PubMed publication ID

23 February 2018

http://europepmc.org/abstract/MED/21745524

Triple therapy for Helicobacter pylori eradication is more effective than long-term maintenance antisecretory treatment in the prevention of recurrence of duodenal ulcer: a prospective long-term follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.099

7 January 2021

Long-term follow-up of Helicobacter pylori eradication therapy in Vietnam: reinfection and clinical outcome

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.099

7 January 2021

The status of antimicrobial resistance of Helicobacter pylori in eastern Europe.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.099

7 January 2021

Evaluation of therapeutic efficacy of adjuvant Helicobacter pylori whole cell sonicate in mice with chronic H. pylori infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.099

7 January 2021

Mucosal immune responses are related to reduction of bacterial colonization in the stomach after therapeutic Helicobacter pylori immunization in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.099

7 January 2021

Oral immunization with HpaA affords therapeutic protective immunity against H. pylori that is reflected by specific mucosal immune responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.099

7 January 2021

Therapeutic vaccination against Helicobacter pylori in the beagle dog experimental model: safety, immunogenicity, and efficacy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.099

7 January 2021

Therapeutic efficacy of a multi-epitope vaccine against Helicobacter pylori infection in BALB/c mice model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.099

7 January 2021

Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.099

7 January 2021

Intranasal CpG-oligodeoxynucleotide is a potent adjuvant of vaccine against Helicobacter pylori, and T helper 1 type response and interferon-gamma correlate with the protection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.099

7 January 2021

Outer membrane protein a of Salmonella enterica serovar Typhimurium activates dendritic cells and enhances Th1 polarization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.099

7 January 2021

Uptake through glycoprotein 2 of FimH(+) bacteria by M cells initiates mucosal immune response

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.099

7 January 2021

Live attenuated Salmonella: a paradigm of mucosal vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.099

7 January 2021

Live Salmonella as vaccines and carriers of foreign antigenic determinants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.099

7 January 2021

Virulence factors of Helicobacter pylori: implications for vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.099

7 January 2021

Development and evaluation of a DNA vaccine based on Helicobacter pylori urease B: failure to prevent experimental infection in the mouse model.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.099

7 January 2021

Oral immunization of mice with lactic acid bacteria producing Helicobacter pylori urease B subunit partially protects against challenge with Helicobacter felis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.099

7 January 2021

Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.099

7 January 2021

A systematic assessment of MHC class II peptide binding predictions and evaluation of a consensus approach

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.099

7 January 2021

Prediction of MHC class II binding affinity using SMM-align, a novel stabilization matrix alignment method

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.099

7 January 2021

FMDV-2A sequence and protein arrangement contribute to functionality of CYP2B1-reporter fusion protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.099

7 January 2021

Characterization of the structure and function of W --> F WW domain variants: identification of a natively unfolded protein that folds upon ligand binding

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.099

7 January 2021

An analysis of protein domain linkers: their classification and role in protein folding

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.099

7 January 2021

Psychological stress enhances the colonization of the stomach by Helicobacter pylori in the BALB/c mouse

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.099

7 January 2021

Evaluation of DNA extraction methods from mouse stomachs for the quantification of H. pylori by real-time PCR.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.099

7 January 2021

Protection of mice against gastric colonization by Helicobacter pylori by single oral dose immunization with attenuated Salmonella typhimurium producing urease subunits A and B.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.099

7 January 2021

Vaccination of mice with live recombinant Salmonella typhimurium aroA against H. pylori: parameters associated with prophylactic and therapeutic vaccine efficacy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.099

7 January 2021

A murine model of intranasal immunization to assess the immunogenicity of attenuated Salmonella typhi live vector vaccines in stimulating serum antibody responses to expressed foreign antigens.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.099

7 January 2021

Impact of vector-priming on the immunogenicity of a live recombinant Salmonella enterica serovar typhi Ty21a vaccine expressing urease A and B from Helicobacter pylori in human volunteers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.099

7 January 2021

Safety and immunogenicity of phoP/phoQ-deleted Salmonella typhi expressing Helicobacter pylori urease in adult volunteers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.099

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.099

7 January 2021

Specific T cell responses to Helicobacter pylori predict successful eradication therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.099

7 January 2021

Therapeutic effects of molecularly designed antigen UREB138 for mice infected with Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.099

7 January 2021

A urease-negative mutant of Helicobacter pylori constructed by allelic exchange mutagenesis lacks the ability to colonize the nude mouse stomach.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.099

7 January 2021

based on heuristic

inferred from DOI database lookup

A recombinant Salmonella typhimurium vaccine induces local immunity by four different routes of immunization.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.099

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2011.06.099

1 reference

Europe PubMed Central

PubMed publication ID

23 February 2018

http://europepmc.org/abstract/MED/21745524

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 February 2018

http://europepmc.org/abstract/MED/21745524

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50040740&oldid=1796182031"